13th Annual Prostate Cancer Conference

Thank you to our sponsors!

Platinum Premier

Silver

 Bronze

2024 Conference Agenda

8:30-8:45

Welcome

8:45-9:30

Updates in Urology: Diet, Nutrition, & Testosterone Replacement
Laura Mihalko, MD, Urologist, Raymond G. Murphy VA Medical Center

• Testosterone replacement after treatment
• Impact of diet on prostate cancer outcomes

9:30-9:40

Questions on presentation 1

9:40-9:45

Break

9:45-10:30

Radiopharmaceuticals (‘Theranostics’) in Prostate Cancer: Recent Advances in Imaging and Treatment Utilizing PSMA

Gregg Franklin, MD, PhD, Radiation Oncologist, New Mexico Cancer Center 

• Radiopharmaceuticals and Theranostics: a brief history, background physics, and general concepts for both
• Background and details of PSMA PET/CT scans, brief review of trials leading to the current FDA-approved imaging agents, and future upcoming agents
•  Background and details of the pivotal VISION trial leading to Pluvicto FDA-approval including side effects and radiation precautions, as well as recent trial data in the pre-chemotherapy setting and future upcoming trials

10:30-10:40

Questions on presentation 2

10:40-10:50

Break

10:50-11:35

Advanced and Recurrent Prostate Cancer

Dr. Andrea Teague, Medical Oncologist, CHRISTUS St. Vincent Regional Medical Center

• Determining location of the cancer using scans
• Androgen deprivation therapy
• Options for treatment of bone only metastatic prostate cancer
• Role of radionucleotide therapy
• Chemotherapy options for advanced/metastatic prostate cancer
• Targeted agents for advanced/metastatic prostate cancer

11:35-11:45

Questions on presentation 3

11:45-11:50

Break

11:50-12:30

Genetic Testing in Prostate Cancer

Christi Capers, Field Medical Director, Pfizer

• Biomarkers in prostate cancer
• Types of tests being done
• HRR mutations and how often do they happen
• Testing guidelines for prostate cancer

 12:30-12:40

Questions on presentation 4

12:40-12:45

Closing remarks & thanks

Conference Presenters

Christi Capers, PhD

Field Medical Director
Pfizer

Presenter Bios

Laura Mihalko, MD

Dr. Laura Mihalko is a practicing urologist at the Raymond G. Murphy VA Hospital. She is originally from the Detroit area and completed her undergraduate degree in microbiology at the University of Michigan. Dr. Mihalko spent several years working in a research lab studying breast cancer and melanoma. After her time at the University of Michigan, she completed her medical school education at the University of Toledo College of Medicine and Health Sciences. Her interests in both surgery and oncology led her to specialize in urologic surgery. Dr. Mihalko then completed her residency training at the University of New Mexico in urology and has stayed in Albuquerque since finishing her training. Her primary focuses are prostate and renal malignancies. During her free time, Dr. Mihalko spends time with her two children, husband, and two dogs.  

Gregg Franklin, MD, PhD

Gregg Franklin is a board-certified radiation oncologist and currently serves as the medical director of radiation oncology at the New Mexico Cancer Center.  Prior to working at the New Mexico Cancer Center since 2005, he completed his residency at Washington University/Barnes Jewish Hospital in St. Louis, Missouri.  Prior to his MD degree, Dr. Franklin earned a Ph.D. in condensed matter physics at the University of Illinois at Urbana-Champaign.  Between these degrees, from 1992 through 1996, he was a postdoctoral fellow at Harvard University and a scientist with Sandia National Laboratory in Albuquerque, NM. He is currently a fellow with the American Society for Radiation Oncology (ASTRO), American College of Radiology (ACR) and with the American Society for Clinical Oncology College of Radiation Oncology (ASCO).

Andrea Teague, MD

Dr. Andrea Teague is a hematology-oncology specialist with  CHRISTUS St. Vincent Regional Cancer Center in Santa Fe and Vice President of Cancer Services for CHRISTUS Health. She earned her medical degree from Albany Medical College, graduating Cum Laude. She completed her residency in Internal Medicine and Pediatrics at Albany Medical Center where she served as Chief Resident for one year. She was fellowship-trained in hematology and oncology at Washington University in St. Louis.  Dr. Teague is board certified in Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology and the American Society of Hematology.  She is actively involved in clinical trial research and expanding services for cancer patients in northern New Mexico.

Christi Capers

Christi is a field medical director for Pfizer, one of the largest oncology pharmaceutical companies in the world.  She has over 26 years’ experience in various aspects of medical care.  For the last 16 years, her focus has been primarily in cancer care.  Currently, she works with healthcare providers, oncology researchers, and oncology advocacy groups to provide education and clinical trial opportunities in cancers involving the prostate, kidneys, and bladder for Pfizer.  Christi currently resides in Nashville, Tennessee where she has lived for most of her life.